← Back to Search

Behavioral Intervention

Experimental group for Aging

N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]
Awards & highlights

Study Summary

This trial aims to see if a memory improvement technique works well for older people.

Who is the study for?
This trial is for English-speaking adults who are experiencing normal aging or have mild cognitive impairment (MCI). It's not suitable for those with a history of significant psychiatric illness, alcohol or drug abuse requiring inpatient treatment, current use of benzodiazepines and steroids, prior stroke, neurological injury/disease, or dementia.Check my eligibility
What is being tested?
The study is testing a memory enhancement technique called STEM. The goal is to see if this method can improve new learning and memory in individuals who are aging healthily as well as those with MCI.See study design
What are the potential side effects?
Since the intervention involves a non-invasive educational technique focused on memory improvement, no direct physical side effects are expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]
This trial's timeline: 3 weeks for screening, Varies for treatment, and three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participation in Everyday life
Verbal Leaning task
Secondary outcome measures
Functional Neuroimaging

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental groupExperimental Treatment1 Intervention
The experimental group will receive memory techniques training administered twice a week for four weeks (8 training sessions).
Group II: Control groupPlacebo Group1 Intervention
The control group will receive memory exercises administered twice a week for four weeks (8 sessions).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STEM
2019
N/A
~1030

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
174 Previous Clinical Trials
10,698 Total Patients Enrolled
1 Trials studying Aging
33 Patients Enrolled for Aging

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing efforts to enlist participants for this trial?

"Information from clinicaltrials.gov shows that this particular research endeavor is not currently accepting applicants. The trial was initially shared on March 1, 2024, and the most recent update occurred on February 13, 2024. Despite this study no longer actively seeking participants, there are currently 230 other studies in search of eligible individuals for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI
Nancy Chiaravalloti 2024. "Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06269939.
All > Memory
~27 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top